首页> 美国政府科技报告 >Cis-Acting Sequences Required for Inducible Interleukin-2 Enhancer Function Binda Novel Ets-Related Protein, Elf-1
【24h】

Cis-Acting Sequences Required for Inducible Interleukin-2 Enhancer Function Binda Novel Ets-Related Protein, Elf-1

机译:可诱导白细胞介素-2增强子功能所需的顺式作用序列Binda新型Ets相关蛋白,Elf-1

获取原文

摘要

The recent definition of a consensus DNA binding sequence for the Ets family oftranscription factors has allowed the identification of potential Ets binding sites in the promoters and enhancers of many inducible T-cell genes. In the studies described in this report, we have identified two potential Ets binding sites, EBSI and EBS2, which are conserved in both human and murine interleukin-2 enhancers. Within the human enhancer, these two sites are located within the previously defined DNase I footprints, NFAT-1 and NFIL-2B, respectively. Electrophoretic mobility shift and methylation interference analyses demonstrated that EBS1 and EBS2 are essential for the formulation of the NFAT-1 and NFIL-2B nuclear protein complexes. Furthermore, in vitro mutagenesis experiments demonstrated that inducible interleukin-2 enhancer function requires the presence of either EBS1 and EBS2. Two well-characterized Ets family members, Ets-1 and Ets-2, are reciprocally expressed during T-cell activation. Surprisingly, however, neither of these proteins bound in vitro to EBS1 and EBS2.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号